LabCorp and Quest exclusivity

Note: Not sure how "visibility" and "consumer should control" helps them from not have a Race to the bottom. Just proves that OPK needs to spend up Claros.


No exclusive deal, no problem: Quest and LabCorp shares surge on optimism

Both Quest Diagnostics and LabCorp lost exclusive contracts, but their stocks surged following the news.
Analysts said the pair of announcements may indicate that the lab services didn't have to resort to rock-bottom pricing to hold onto their agreements.
Experts also said that the companies likely won't suffer when it comes to market share.

....

A few years ago, Quest and LabCorp came under pressure when would-be disruptor Theranos claimed it had developed a revolutionary machine that could provide test results from just one drop of blood. In March, the SEC charged Theranos' founder Elizabeth Holmes with what it called massive fraud.

When asked for his thoughts on the rise and fall of the start-up, Rusckowksi said there was one good thing that came out of the hype.

"It added a lot of visibility to our marketplace, a lot of attention placed on lab testing... and how the consumer should control it," he said. "It helped us to amplify what we're doing and now we're delivering on that promise."